Repligen



Ebitda változás Dátum
Agilent USD 484M 20M 2025-01
Align Technology USD 215.22M 15.06M 2024-12
Bio Techne USD 82.13M 975K 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Bruker USD 161.7M 29.3M 2024-12
Charles River Laboratories USD 192.3M 43.95M 2024-12
Danaher USD 2.02B 365M 2024-12
Dentsply International USD 126M 30M 2024-12
Exact Sciences USD 14.96M 19.11M 2024-12
General Electric USD 2.82B 358M 2024-12
Henry Schein USD 281M 0 2024-12
Illumina USD 281M 48M 2024-12
IQVIA Holdings USD 925M 69M 2024-12
Mettler Toledo International USD 365.41M 54.15M 2024-12
Myriad Genetics USD -2100000 100K 2024-12
Patterson Companies USD 76.73M 16.21M 2025-01
Pfizer USD 4.71B 3.04B 2024-12
Repligen USD 4.9M 22.12M 2024-09
Revvity USD 216.63M 5.1M 2024-12
Standard Biotools USD -25783000 5.4M 2024-12
Thermo Fisher Scientific USD 2.99B 363M 2024-12
Waters USD 340.84M 80.08M 2024-12
West Pharmaceutical Services USD 208.6M 4.5M 2024-12



Repligen - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Apr 2025.